NCT00307281 Emphysema Research Registry and Biosample Repository
| NCT ID | NCT00307281 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pittsburgh |
| Condition | Emphysema |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2000-08 |
| Primary Completion | 2030-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2000-08 with a primary completion date of 2030-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Comprehensive Lung Center (CLC) at the University of Pittsburgh Medical Center (UPMC Health System) provides patients with any type of breathing or lung disorder a full range of diagnostic and therapeutic services. The Emphysema/COPD Research Center (ECRC) is a specialty clinic, within this center, that attempts to advance the understanding of emphysema and to evaluate new therapies for patients with emphysema. The Emphysema Research Registry will enable pulmonary research physicians to: 1) gather information and create a research registry of people who have been diagnosed with emphysema; 2) utilize this research registry with the purpose of conducting research that attempts to advance the understanding of emphysema and to evaluate new therapies; and, 3) use the research registry to identify potential candidates for future research programs. These aims will be achieved by the collection of DNA (genetic material)for analysis and storage in addition to pulmonary function tests and other medical information.
Eligibility Criteria
Inclusion Criteria: * Patients would be required to have COPD based on at least one of the following: clinical history, pulmonary function results, or radiographic results. Exclusion Criteria: * none
Contact & Investigator
Frank C. Sciurba, MD
PRINCIPAL INVESTIGATOR
University of Pittsburgh Medical Center
Frequently Asked Questions
Who can join the NCT00307281 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, studying Emphysema. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00307281 currently recruiting?
Yes, NCT00307281 is actively recruiting participants. Contact the research team at consolaropj@upmc.edu for enrollment information.
Where is the NCT00307281 trial being conducted?
This trial is being conducted at Pittsburgh, United States.
Who is sponsoring the NCT00307281 clinical trial?
NCT00307281 is sponsored by University of Pittsburgh. The principal investigator is Frank C. Sciurba, MD at University of Pittsburgh Medical Center. The trial plans to enroll 3,000 participants.